Daiichi Sankyo Co Ltd

Daiichi Sankyo discloses a partial framework for keeping its policy engagement in line with its climate goals. It states that the company has "a public commitment ... to conduct our engagement activities in line with the goals of the Paris Agreement," and outlines a concrete mechanism for indirect lobbying alignment by noting that "å½"社サステナãƒ"リティ推進部のメンバーがリーダーとだ- て参ç"»ã - ...主導的な役割ã‚'果ただ- ています" in the climate-change task-force of the Japan Pharmaceutical Manufacturers Association, which led the industry body to adopt a "2050年カーボンニュートラル" vision and a 46 % COâ‚‚-reduction target for 2030. This indicates the company is actively working to align at least one key trade association with its own climate commitments. Governance of wider environmental strategy is overseen by the "EHS経å - ¶å§"å"¡ä¼š," chaired by the Chief EHS Officer and reporting to the board twice a year, but the disclosure does not clarify whether this committee specifically reviews or approves lobbying positions, nor does it name any individual or board committee formally charged with monitoring lobbying alignment. We found no public description of a systematic, recurring review of the company's direct lobbying, criteria for assessing other associations, or a published climate-lobbying alignment report. Overall, the company shows some mechanisms and commitments that indicate moderate governance of indirect climate-related lobbying, but the disclosure of monitoring procedures, responsible oversight parties and coverage of direct lobbying remains limited.